Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Short summary

Continuing dual antiplatelet therapy (DAPT) with thienopyridine and aspirin for 30 months after drug-eluting stent placement significantly reduced stent thrombosis (0.4% vs. 1.4%) and major adverse cardiovascular events (4.3% vs. 5.9%) compared to stopping thienopyridine at 12 months, but increased bleeding risk (2.5% vs. 1.6%).

AI-generated from the title and abstract; the full text is not read.